Evaluation of quantitative assay for antibody to hepatitis C virus core in patients treated with interferon

Digestive Diseases and Sciences

Volumn 41, Issue 1, 1996, Pages 155-160

  Yoshimura, Eriko ^a   Hayashi, Jun ^a   Kishihara, Yasuhiro ^a   Yamaji, Kohzaburo ^a   Kinukawa, Naoko ^a   Kashiwagi, Seizaburo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; Hepatitis C virus core antibody; Hepatitis C virus RNA; Interferon

Indexed keywords

ALPHA INTERFERON; ENDOGENOUS COMPOUND; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; VIRUS CORE;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL CORE PROTEINS;

EID: 0030064641     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02208598     Document Type: Article

References (20)

1. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364, 1989
2. Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida A, Miyakawa Y, Mayumi M: Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol 72:2697-2704, 1991
3. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, di Nello R, van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvaar-Kuypers, Polito A, Houghton M, Lelie PN: Confirmation of hepatitis C virus infection by new four-antigen recombinant blot assay. Lancet 337:317-319, 1991
4. Hayashi J, Nakashima K, Yoshimura E, Hirata M, Maeda Y, Kashiwagi S: Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan. J Gastroenterol 29:147-151, 1994
5. Hayashi J, Nakashima K, Yoshimura E, Kishihara Y, Ohmiya M, Hirata M, Kashiwagi S: Prevalence and role of hepatitis C viremia in hemodialysis patients in Japan. Infect 28:217-277, 1994
6. Hayashi J, Nakashima K, Kishihara Y, Ohmiya M, Yoshimura E, Hirata M, Kashiwagi S: Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease. J Infect 26:287-294, 1993
7. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M: Detection of hepatitis C virus RNA by at two-stage polymerase chain reaction with two pairs of primers deduced from the 5′ -noncoding region. Jpn J Exp Med 60:215-222, 1990
8. Hayashi J, Ohmiya M, Kishihara Y, Tani Y, Kinukawa N, Ikematu H, Kashiwagi S: A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol 89:2151-2156, 1994
9. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M: Quantitation of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 18:16-20, 1993
10. Sherman KE, O'brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P, Wilber J: Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 31:2679-2682, 1993
11. Yoshimura E, Hayashi J, Tani Y, Ohmiya M, Nakashima K, Ikematu H, Kinukawa N, Maeda Y, Kashiwagi S: Inverse correlation between the titer of antibody to hepatitis C virus and the degree of hepatitis C viraemia. J Infect 29:147-155, 1994
12. Urushihara A, Sodeyama T, Matsumoto A, Tanaka E: Changes in antibody titers to hepatitis C virus following interferon therapy for chronic interferon. J Med Virol 42:348-356, 1994
13. Yuki N, Hayashi N, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T: Quantitative analysis of antibodies to hepatitis C virus during interferon-α therapy. Hepatology 17:960-965, 1993
14. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
15. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian K-P, Kohara M, Simmonds P, Urdea MS: Application of six hepatitis C virus genotype systems to sera from chronic hepatitis C patients in the united states. J Infect Dis 171:281-289, 1995
16. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T Fukuda S, Tsuda F, Mishiro S: Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four district genotypes. Virology 188:331-341, 1992
17. Dixon WJ, Massey FJ Jr: Introduction to Statistical Analysis, 4th ed. New York, McGraw-Hill, 1983
18. Encyclopedia of Statistical Sciences, Kotz S, Johnson NL (eds.) Vol 2:p204, 1982, New York, John Wiley & Sons
19. Hayashi J, Nakashima K, Noguti A, Hirata M, Akazawa K, Kashiwagi S: Antiviral effect of interferon therapy for patients with chronic hepatitis C. Antiviral Chem Chemother 3:305-309, 1992
20. Banffer JRJ, Brunings EA, Gielis-Proper FK, Schmitz PIM: The epidemiology of hepatitis B infection in a poly-ethnic population. Am J Epidemiol 107:501-506, 1977